Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies

Biologics to TNF family receptors are prime candidates for therapy of immune disease. Whereas recent studies have highlighted a requirement for Fcγ receptors in enabling the activity of CD40, TRAILR, and GITR when engaged by antibodies, other TNFR molecules may be controlled by additional mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Madireddi, Shravan, Eun, So-Young, Lee, Seung-Woo, Nemčovičová, Ivana, Mehta, Amit Kumar, Zajonc, Dirk M., Nishi, Nozomu, Niki, Toshiro, Hirashima, Mitsuomi, Croft, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076583/
https://www.ncbi.nlm.nih.gov/pubmed/24958847
http://dx.doi.org/10.1084/jem.20132687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076583/
https://www.ncbi.nlm.nih.gov/pubmed/24958847
http://dx.doi.org/10.1084/jem.20132687

Ejemplares similares